Kanoria Chemicals turns profitable in FY26: ₹113 cr profit

Key development: FY26 profit after prior-year loss

Kanoria Chemicals & Industries Limited reported a consolidated net profit of ₹113.20 crore for FY26, reversing a consolidated net loss of ₹108.15 crore in the previous year. The company attributed this turnaround to a gain on loss of control of discontinued operations, as stated in the update. While the headline FY26 number marks a swing from loss to profit, it also signals that non-operating or one-off items played a role in the reported profitability. For investors, the disclosure matters because it separates core operating progress from gains linked to corporate actions or discontinued operations.

The company’s updates also include quarter and nine-month performance trends, which help contextualise whether the profitability improvement is reflected in ongoing operations. In addition to financial performance, Kanoria Chemicals filed a compliance certificate for the quarter ended March 31, 2026, with NSE and BSE under SEBI Regulation 74(5). The company also reported a favourable legal outcome in a tax-related matter after the Supreme Court dismissed an appeal filed by the Commissioner of Income Tax-IV, Kolkata.

Compliance filing with NSE and BSE under SEBI Regulation 74(5)

Kanoria Chemicals said it filed its compliance certificate for the quarter ended March 31, 2026, with the stock exchanges. The filing was made under SEBI Regulation 74(5), which relates to compliance requirements around securities held in dematerialised form. Such filings are routine, but they remain important for listed companies because they provide documented confirmation of adherence to regulatory processes.

For market participants, these disclosures are typically viewed as hygiene indicators rather than performance drivers. Still, timely compliance helps maintain transparency for shareholders and reduces the risk of procedural issues that could distract management during periods when operating performance is under scrutiny.

Q3FY26: standalone revenue growth and return to profit

In Q3FY26, the company reported standalone revenue of ₹230.59 crore, up 42% year-on-year. The same standalone results showed a return to profitability, with net profit at ₹3.93 crore compared with a net loss of ₹19.70 crore in Q3FY25. The company described this as a significant turnaround in quarterly profitability versus the year-ago period.

Alongside the revenue increase, the improvement in profit signals better earnings quality compared with a loss-making base. However, the company’s broader FY26 swing was also driven by a gain on loss of control of discontinued operations, which means investors may look closely at the split between operating and non-operating drivers when assessing sustainability.

Nine-month FY26: standalone income and profit improve

For the nine months ended December 31, 2025, Kanoria Chemicals reported standalone Total Income of ₹626.47 crore and profit after tax of ₹5.76 crore. Separately, it also reported nine-month revenue of ₹608.00 crore, up 25%, with net profit of ₹5.76 crore against the previous year’s loss of ₹19.57 crore.

These nine-month figures indicate a shift into positive territory versus a loss in the comparable period last year. The numbers also provide more coverage than a single quarter, which can help investors evaluate whether the business is stabilising across periods. The company’s release framed the outcome as a move back to profitability during FY26.

Consolidated Q3 and nine-month performance

On a consolidated basis, Kanoria Chemicals reported Q3FY26 revenue from operations of ₹265.82 crore compared with ₹180.35 crore in Q3FY25, a 47% year-on-year increase. Consolidated net profit for the quarter stood at ₹3.55 crore against a loss of ₹28.63 crore in the prior-year quarter. The company also reported consolidated Total Income for the quarter at ₹268.21 crore, up from ₹181.41 crore.

For the nine months, consolidated revenue reached ₹677.04 crore, up from ₹540.43 crore. The company reported consolidated net profit of ₹81.58 crore for the nine months, compared with a loss of ₹68.04 crore in the corresponding period last year. These consolidated numbers show a stronger swing than the standalone nine-month profit figure, implying that group-level factors and consolidation effects materially influenced reported profitability.

Board approval and disclosure timeline

Kanoria Chemicals announced its un-audited financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved the standalone and consolidated results during a meeting held on February 12, 2026, which commenced at 12:15 p.m. and concluded at 3:00 p.m. The company also referenced the announcement of its Q3 FY 2025-26 results on February 13, 2026.

Such time-stamped disclosures are typically part of exchange filing requirements. For investors, the details confirm that the results were reviewed and approved by the board, and they help establish a clear reporting sequence across quarters.

Q2FY26 comparison: sharp PAT swing versus Q3

The company also reported Q2FY26 performance, which shows how volatile quarterly net profit can be when non-operating items are present. Profit before tax for Q2FY26 was ₹1.15 crore, an improvement compared with losses of ₹10.46 crore in Q1FY26 and ₹9.38 crore in Q2FY25. Tax expense for Q2FY26 was ₹3.39 crore, compared with ₹3.32 crore in Q1FY26 and ₹7.10 crore in Q2FY25.

Despite the relatively small profit before tax, the company reported profit after tax of ₹91.81 crore in Q2FY26, compared with losses of ₹13.78 crore in the previous quarter and ₹16.48 crore in the same quarter last year. For Q3FY26, profit before tax was stated at ₹5.73 crore, up from ₹1.15 crore in Q2FY26, while profit after tax for Q3FY26 was ₹3.55 crore, sharply lower than ₹91.81 crore in Q2FY26 but improved from the loss of ₹28.63 crore in Q3FY25.

Supreme Court tax matter: appeal dismissed

Kanoria Chemicals disclosed that the Supreme Court of India dismissed an appeal filed by the Commissioner of Income Tax-IV, Kolkata on January 28, 2026. The company described the outcome as favourable in a tax-related legal matter.

While the disclosure does not quantify the financial impact in the provided details, resolution of tax litigation can reduce uncertainty for investors. It can also lower the risk of contingent liabilities influencing future reported earnings, depending on the nature of the case.

Key figures at a glance

Market impact: what investors typically track from here

The FY26 profit swing and improving year-on-year quarterly numbers may draw attention to the company’s earnings trajectory, but the disclosures also highlight the role of one-off drivers such as gains linked to discontinued operations. Investors typically track whether revenue growth translates into consistent operating profit across multiple quarters, especially when prior quarters show large profit volatility.

The difference between Q2FY26 profit after tax of ₹91.81 crore and Q3FY26 profit after tax of ₹3.55 crore underscores why market participants focus on the quality of earnings and the presence of exceptional items. In parallel, updates such as the SEBI Regulation 74(5) compliance certificate and the Supreme Court tax matter outcome reduce procedural and legal overhang, even if they do not directly change near-term operations.

Conclusion

Kanoria Chemicals & Industries reported a consolidated profit of ₹113.20 crore in FY26, reversing the prior-year loss, with the company citing a gain related to discontinued operations as a key driver. Quarterly and nine-month disclosures show year-on-year improvement in revenue and profitability in Q3FY26 and over the nine-month period, alongside notable quarter-to-quarter profit volatility. The company has also made regulatory compliance filings for the March 2026 quarter and reported a favourable Supreme Court outcome in a tax appeal. Future filings and results will be watched for clarity on how much of the profitability improvement is sustained through core operations versus exceptional items.